| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |